13 September 202113 September 2021 Y. Ben-Ari

Servier and Neurochlore announce the main results of the two phase 3 clinical studies assessing bumetanide in the treatment of Autism Spectrum Disorders in children and adolescents

15 June 2021 Y. Ben-Ari

The challenges of in-vivo GABA and glutamate measurements in the preterm neonatal brain

8 April 2021 Y. Ben-Ari

Cesarean Section delivery in mice leads to smaller brain volumes at birth

30 March 202130 March 2021 Y. Ben-Ari

There is not a single Autism-specific gene, just brain genes !

25 March 202125 March 2021 Y. Ben-Ari

Use of machine learning to identify at birth babies at risk of developing Autism Spectrum Disorders

25 February 202125 February 2021 Y. Ben-Ari

The Complex effects of Anti-Epileptic Drugs and Neonatal Seizures

18 February 202118 February 2021 Y. Ben-Ari

How does a Benzodiazepine produce a transient awakening of patients under severe long-lasting comatose state due to heavy brain lesions ?

17 February 2021 Y. Ben-Ari

A new report contributes to the promising Bumetanide treatment for autism. Further studies should confirm this approach

10 February 2021 Y. Ben-Ari

Of mice and men: how studying brain development helps developing treatments of autism

17 November 2020 Y. Ben-Ari

6 clinical trials now confirm the efficacy of Bumetanide to treat Autism Spectrum Disorders